Animal Parasiticides Market Outlook 2031: Projected to Reach US$15.6 Billion, with a 5.7% CAGR | Exclusive Report by TMR

The global animal parasiticides market, valued at US$9.4 billion in 2022, is poised for significant growth over the next decade. It is estimated to expand at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2031, reaching US$15.6 billion by the end of 2031. This robust expansion reflects the increasing need to protect livestock and companion animals from parasitic infections, driven by rising animal health awareness, agricultural demands, and advancements in parasiticide formulations. As global focus on food security and pet care intensifies, the animal parasiticides market is set to play a vital role in veterinary medicine through 2031.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10841

Understanding the Animal Parasiticides Market

Animal parasiticides are chemical or biological agents used to prevent, control, or eliminate parasites such as fleas, ticks, worms, and mites in animals. Available as topical solutions, oral tablets, injectables, and sprays, they target both external (ectoparasites) and internal (endoparasites) threats. The market's 2022 valuation of US$9.4 billion underscores its established importance, with the projected rise to US$15.6 billion by 2031 highlighting its growing necessity amid expanding animal populations and health challenges.

The 5.7% CAGR signals a steady yet dynamic growth phase, balancing traditional products with innovative solutions. Parasiticides are essential for animal welfare, productivity, and zoonotic disease prevention, ensuring sustained market momentum.

Key Drivers of Market Growth

Several factors are propelling the animal parasiticides market toward its US$15.6 billion milestone by 2031. First, the rising global demand for animal-derived food is a primary driver. With a growing population and increasing meat, dairy, and egg consumption, livestock health is critical for food security. Parasiticides protect cattle, poultry, and swine from productivity losses caused by infestations, aligning with the market's 5.7% CAGR as agricultural output scales up.

Second, the surge in pet ownership is boosting demand. Urbanization and higher disposable incomes have elevated the status of pets as family members, particularly in developed regions. Owners are investing in parasiticides to safeguard dogs, cats, and other companions from fleas, ticks, and heartworms, driving growth in this segment alongside livestock applications.

Third, climate change and parasite resistance are spurring innovation. Warmer temperatures expand parasite habitats, increasing infection risks, while resistance to older chemistries-like organophosphates-necessitates new formulations. Advances in long-acting parasiticides, combination therapies, and eco-friendly biopesticides address these challenges, supporting the market's trajectory to US$15.6 billion.

Leading Players:

Bayer AG
Bimeda Animal Health
Boehringer Ingelheim GmbH
Ceva Sante Animale
Elanco (Eli Lilly and Company)
Merck & Co., Inc.
Vetoquinol
Zoetis, Inc.
Virbac
The Chanelle Group
Sunmitomo Chemical Co., Ltd.
Others

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10841

Market Segmentation and Regional Insights

The market segments by product type, animal type, and geography. Ectoparasiticides (e.g., fipronil, permethrin) lead due to their widespread use against external parasites, followed by endoparasiticides (e.g., ivermectin) for worms. Combination products addressing both types are gaining traction. Livestock dominates, reflecting agricultural needs, while companion animals show rapid growth due to pet care trends.

Regionally, North America held a significant share of the US$9.4 billion valuation in 2022, driven by advanced veterinary care and high pet ownership in the United States. Europe followed, with strong markets in Germany and the UK, supported by stringent animal health regulations. The Asia-Pacific region, however, is expected to experience the fastest growth through 2031, fueled by expanding livestock production, rising pet adoption, and improving veterinary infrastructure in China and India.

Challenges and Opportunities

The market faces challenges. Regulatory restrictions on chemical parasiticides, due to environmental and safety concerns, can limit product availability. Resistance to existing treatments reduces efficacy, requiring ongoing R&D investment, while high costs may deter adoption in low-income regions. Competition from alternative pest control methods, like vaccines or natural repellents, also poses a threat.

These challenges, however, present opportunities. Companies developing safer, resistance-resistant parasiticides-such as novel actives or biologics-could gain a competitive edge, supporting the push to US$15.6 billion. Expanding education and affordable options in emerging markets could boost uptake, as could innovations like wearable parasiticide delivery (e.g., collars) or integrated pest management systems. Partnerships with governments to combat zoonotic diseases offer further growth potential.

The Road to 2031

By 2031, the global animal parasiticides market is expected to reach US$15.6 billion, reflecting nine years of solid growth at a 5.7% CAGR from US$9.4 billion in 2022. This achievement is driven by agricultural needs, pet care trends, and innovative responses to evolving threats. As the forecast period concludes, the market's trajectory suggests continued relevance, with potential for new applications-like parasite control in aquaculture-to drive future expansion.

In conclusion, the animal parasiticides market demonstrates strong growth from 2022 to 2031. Rising from US$9.4 billion to US$15.6 billion, it addresses critical needs in animal health and food production. Stakeholders-from manufacturers to veterinarians-play a vital role in this success, ensuring that effective, accessible solutions protect animals worldwide through 2031 and beyond.

Explore Latest Research Reports by Transparency Market Research:

Veterinary Ventilators Market: https://www.pharmiweb.com/press-release/2025-03-18/veterinary-ventilators-market-to-surpass-us-13-bn-by-2035-amid-rising-demand-for-advanced-animal-healthcare-solutions-tmr-research

Wearable Pulse Oximeters Market: https://www.pharmiweb.com/press-release/2025-03-18/wearable-pulse-oximeters-market-to-surpass-us-5945-mn-by-2031-amid-rising-demand-for-smart-health-monitoring-solutions-tmr-research

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

This release was published on openPR.